Novo Nordisk argues that those permissions do not override existing patent rights and do not allow companies to replicate a patented drug simply because demand is high or access is constrained
However, tirzepatide has the significant advantage of FDA approval, which opens the door to insurance coverage
It is the time taken for half of the administered dose of a drug to be eliminated from the body
Large-scale CVOTs have demonstrated that GLP-1 RAs significantly reduce the incidence of MACE, including cardiovascular death, non-fatal MI and non-fatal stroke
Tirzepatide, a GLP-1 receptor agonist , is not only a potent tool for blood sugar control in people with type 2 diabetes but also a standout solution for those seeking to shed excess weight
Liraglutide, or Victoza, has come off patent in June of 2024 but requires a daily injection instead of weekly